A synthetic tetrapeptide having an amino acide sequence, Glycine-Proline-Arginine-Proline
(GPRP) has pro-inflammatory effects on human fibroblastic cells, including synovial
cells. An amide analog of GPRP is ineffective in inducing, or effective in causing
a loss of, pro-inflammatory effects.